(Q73067271)
Statements
Effectiveness of 3TC in HIV clinical trials may be due in part to the M184V substitution in 3TC-resistant HIV-1 reverse transcriptase (English)
M A Wainberg
M Hsu
Z Gu
G Borkow
1 December 1996
scientific article published on 01 December 1996